Insider Activity for Investors: Ritter Pharmaceuticals, Inc. (RTTR)

nike earnings

Ritter Pharmaceuticals, Inc. (RTTR) belonging to the Medical sector has declined -8.75% and closed its last trading session at $0.73.

The company reported its EPS on 02/27/2017. Currently, the stock has a 1 Year Price Target of $5.5.

The consensus recommendation, according to Zacks Investment research, is 1.4. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.

The Stock had a 1.4 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.

Ritter Pharmaceuticals, Inc. on 02/27/2017 reported its EPS as $-0.74 with the analysts projecting the EPS of the stock as $-0.35. The company beat the analyst EPS Estimate with the difference of $-0.39. This shows a surprise factor of -111.4%.

Many analysts have provided their estimated foresights on Ritter Pharmaceuticals, Inc. Earnings, with 3 analysts believing the company would generate an Average Estimate of $-0.38.

Whereas they predicted High and Low Earnings Estimate as $-0.29 and $-0.52 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.36.

Analysts are also projecting an Average Revenue Estimate for Ritter Pharmaceuticals, Inc. as $3000 in the Current Quarter.

For the Current Quarter, the growth estimate for Ritter Pharmaceuticals, Inc. is -5.6%, while for the Next Quarter the stock growth estimate is 43.7%.

 

Insider Trades for Ritter Pharmaceuticals, Inc. show that the latest trade was made on 26 Feb 2017 where Step (Michael D), the Chief Executive Officer completed a transaction type “Buy” in which 2000 shares were traded at a price of $2.64.

 

 

Ritter Pharmaceuticals, Inc. (RTTR) has the market capitalization of $8.67 Million. The company rocked its 52-Week High of $3.75 and touched its 52-Week Low of $0.68.

The stock has Return on Assets (ROA) of -178.9 percent. Return on Equity (ROE) stands at -252.6% and Return on Investment (ROI) of 0 percent.

The stock is currently showing YTD performance of -73.06 Percent. The company has Beta Value of 0 and ATR value of 0.15. The Weekly and Monthly Volatility stands at 14.23% and 14.26%.